this double-blind , randomized , placebo crossover study was used to evaluate the effects of a cholinesterase inhibitor -- slow-release pyridostigmine ( 180 mg orally every 12 hours ) -- on the anticholinergic and antiarrhythmic properties of disopyramide .
C0003195
antiarrhythmic
C0012702
disopyramide